U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C20H12N2O3S
Molecular Weight 360.386
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of A-769662

SMILES

OC1=CC=CC=C1C2=CC=C(C=C2)C3=CSC4=C3C(O)=C(C#N)C(=O)N4

InChI

InChIKey=CTESJDQKVOEUOY-UHFFFAOYSA-N
InChI=1S/C20H12N2O3S/c21-9-14-18(24)17-15(10-26-20(17)22-19(14)25)12-7-5-11(6-8-12)13-3-1-2-4-16(13)23/h1-8,10,23H,(H2,22,24,25)

HIDE SMILES / InChI

Molecular Formula C20H12N2O3S
Molecular Weight 360.386
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment: Description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/24746562

A-769662 stimulates partially purified rat liver AMPK with EC50 with 0.8 uM. A-769662 activates AMPK purified from multiple tissues and species in a dose-responsive manner with modest variations in observed EC50s. EC50s determined for A-769662 using partially purified AMPK extracts from rat heart, rat muscle, or human embryonic kidney cells (HEKs) are 2.2 uM, 1.9 uM, or 1.1 uM, respectively. A 4 hours treatment of primary rat hepatocytes with A-769662 dose-dependently increases ACC phosphorylation, which correlated inhibition of fatty acid synthesis with IC50 of 3.2 uM. A-769662 also inhibits fatty acid sythesis in mouse hepatocytes with IC50 with 3.6 uM. A-769662 activates AMPK both allosterically and by inhibiting dephosphorylation of AMPK on Thr-172, similar to the effects of AMP. A-769662 inhibits proteasomal function by an AMPK-independent mechanism. A-769662 affects the in vitro activity of purified 26S proteasomes but not the in vitro activity of purified 20S proteasomes. A-769662 has toxic effects on MEF cells. A recent research shows A-769662 inhibited cell proliferation and DNA synthesis.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
576.0 nM [EC50]
Target ID: P05023|||Q9UJ20
Gene ID: 476.0
Gene Symbol: ATP1A1
Target Organism: Homo sapiens (Human)
220.0 µM [IC50]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown

Sample Use Guides

Treatment of ob/ob mice with 30 mg/kg b.i.d. A-769662 decreases hepatic expression of PEPCK, G6Pase, and FAS, lowers plasma glucose by 40%, reduced body weight gain and significantly decreases both plasma and liver triglyceride levels.
Route of Administration: Oral
Short-term incubation of differentiated rat L6 myotubes with 100 uM A-769662 increased AMPK and acetyl-CoA carboxylase (ACC) phosphorylation in parallel with decreased Na(+)-K(+)-ATPase alpha(1)-subunit abundance at the plasma membrane and ouabain-sensitive (86)Rb(+) uptake.
Substance Class Chemical
Created
by admin
on Sat Dec 16 10:04:29 GMT 2023
Edited
by admin
on Sat Dec 16 10:04:29 GMT 2023
Record UNII
P68477CD2C
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
A-769662
Common Name English
4-HYDROXY-3-(2'-HYDROXY-1,1'-BIPHENYL-4-YL)-6-OXO-6,7-DIHYDROTHIENO(2,3-B)PYRIDINE-5-CARBONITRILE
Systematic Name English
THIENO(2,3-B)PYRIDINE-5-CARBONITRILE, 6,7-DIHYDRO-4-HYDROXY-3-(2'-HYDROXY(1,1'-BIPHENYL)-4-YL)-6-OXO-
Systematic Name English
Code System Code Type Description
CAS
844499-71-4
Created by admin on Sat Dec 16 10:04:29 GMT 2023 , Edited by admin on Sat Dec 16 10:04:29 GMT 2023
PRIMARY
EPA CompTox
DTXSID30233425
Created by admin on Sat Dec 16 10:04:29 GMT 2023 , Edited by admin on Sat Dec 16 10:04:29 GMT 2023
PRIMARY
PUBCHEM
54708532
Created by admin on Sat Dec 16 10:04:29 GMT 2023 , Edited by admin on Sat Dec 16 10:04:29 GMT 2023
PRIMARY
FDA UNII
P68477CD2C
Created by admin on Sat Dec 16 10:04:29 GMT 2023 , Edited by admin on Sat Dec 16 10:04:29 GMT 2023
PRIMARY
Related Record Type Details
ACTIVE MOIETY